Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 10768670)

Published in Arch Pediatr Adolesc Med on April 01, 2000

Authors

S W Alander1, M D Dowd, S L Bratton, G L Kearns

Author Affiliations

1: Department of Pediatrics, Children's Mercy Hospital, Kansas City, Mo 64108, USA. salander@cmh.edu

Articles by these authors

Multi-institutional survey of graduates of pediatric anesthesia fellowship: assessment of training and current professional activities. Anesth Analg (1997) 2.67

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther (2007) 2.17

Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet (1992) 1.94

Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet (1999) 1.79

Severe dog bites in children. Pediatrics (1995) 1.78

Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet (1999) 1.67

Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med (2000) 1.56

Acute hepatic failure associated with the use of sodium valproate. N Engl J Med (1979) 1.55

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48

Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46

Pediatric emergency medicine practice patterns: a comparison of pediatric and general emergency physicians. Pediatr Emerg Care (1998) 1.45

Application of pharmacokinetics in the diagnosis of chemical abuse in Münchausen syndrome by proxy. Clin Pediatr (Phila) (1988) 1.38

Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics (1999) 1.36

Acetaminophen overdose with therapeutic intent. J Pediatr (1998) 1.29

Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother (1997) 1.25

Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther (1999) 1.22

Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother (1985) 1.20

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J Pediatr (1982) 1.19

Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther (2007) 1.18

Treatment of neonatal hypertension with enalaprilat. J Pediatr (1990) 1.17

Relationship between socioeconomic factors and severe childhood injuries. J Urban Health (2001) 1.14

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Clin Pharmacol Ther (2000) 1.12

Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am (1997) 1.12

Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther Drug Monit (1982) 1.12

Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr (1991) 1.10

Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol (1992) 1.06

Treatment of pain with gabapentin in a neonate. Pediatrics (2001) 1.05

Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions. Pain (2000) 1.04

Ventilatory response to CO2 in children with obstructive sleep apnea from adenotonsillar hypertrophy. Anesth Analg (1999) 1.02

The neurotoxicity of cyclotrimethylenetrinitramine (RDX) in a child: a clinical and pharmacokinetic evaluation. J Toxicol Clin Toxicol (1986) 1.01

Cocaine: clinical pharmacology and toxicology. J Pediatr (1989) 1.01

Colloid volume expanders. Problems, pitfalls and possibilities. Drugs (1998) 1.01

Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg (1999) 1.00

Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab Dispos (1999) 0.99

Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther (1998) 0.99

Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98

Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery. Anesth Analg (1998) 0.98

A prospective study of femoral catheter-related thrombosis in children. Arch Pediatr Adolesc Med (1995) 0.98

Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther (2001) 0.97

Short vertical falls in infants. Pediatr Emerg Care (1999) 0.97

Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol (2002) 0.96

Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol (2001) 0.96

Survey of the use of peripherally inserted central venous catheters in children. Pediatrics (1997) 0.95

Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth (1999) 0.95

Predictors of successful extubation in children. Am J Respir Crit Care Med (1999) 0.95

Efficacy and complications of percutaneous pigtail catheters for thoracostomy in pediatric patients. Chest (1998) 0.95

Single-dose pharmacokinetics of imipenem in children. J Pediatr (1984) 0.95

Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatr Infect Dis J (1996) 0.94

Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther (1999) 0.93

Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth (1999) 0.93

Serious and fatal air gun injuries: more than meets the eye. Pediatrics (1997) 0.93

The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol (2001) 0.92

Nifedipine poisoning in a child. Pediatrics (1990) 0.92

Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) (2001) 0.91

The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol (1998) 0.91

A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil (1999) 0.90

Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving target. Clin Pharmacol Ther (2012) 0.90

Use of cardiopulmonary bypass during bronchoscopy following sand aspiration. A case report. Chest (1995) 0.89

Bridging the emergency medical services for children information gap. Arch Pediatr Adolesc Med (1999) 0.89

Pregnant mothers out of the perinatal regionalization's reach. J Perinatol (2006) 0.89

Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther (2010) 0.89

Gentamicin pharmacokinetics in neonates with patent ductus arteriosus. Crit Care Med (1997) 0.89

Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm (1998) 0.88

Hospitalizations for pediatric intoxication in Washington State, 1987-1997. Arch Pediatr Adolesc Med (2001) 0.88

Postdural puncture headache in pediatric oncology patients. Clin Pediatr (Phila) (1998) 0.87

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping. Pharmacogenetics (1998) 0.87

Age-related differences in digoxin toxicity and its treatment. Drug Saf (1992) 0.87

Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrob Agents Chemother (1986) 0.87

Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr (1992) 0.86

Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis. J Pediatr (1985) 0.86

The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated. J Nutr (2001) 0.85

Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther (2001) 0.84

Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol (1996) 0.84

Effect of age and renal function on cefonicid pharmacokinetics. Antimicrob Agents Chemother (1989) 0.83

Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrob Agents Chemother (1998) 0.83

High-frequency oscillatory ventilation with partial liquid ventilation in a model of acute respiratory failure. Crit Care Med (1997) 0.83

Antimicrobial therapy for pediatric patients. Pediatr Clin North Am (1989) 0.83

Clinical pharmacology as a foundation for translational science. Clin Pharmacol Ther (2011) 0.83

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping. Clin Pharmacol Ther (1998) 0.82

Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children. Antimicrob Agents Chemother (1995) 0.82

Absence of a pharmacokinetic interaction between chloramphenicol and acetaminophen in children. J Pediatr (1985) 0.82

Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. Crit Care Med (1997) 0.82

Serum sickness-like reactions associated with cefprozil therapy. J Pediatr (1994) 0.82

Suicide with an air rifle. Ann Emerg Med (1997) 0.81

Family violence: implications for the pediatrician. Pediatr Rev (1998) 0.81

Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg (1998) 0.81

Thyroid function in infants following cardiac surgery: comparative effects of iodinated and noniodinated topical antiseptics. Crit Care Med (1997) 0.81

Adverse pulmonary responses to aspirin and acetaminophen in chronic childhood asthma. Pediatrics (1983) 0.81

Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. J Clin Pharmacol (1998) 0.81

Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol (1998) 0.81

Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum. Antimicrob Agents Chemother (1988) 0.81

Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila) (1999) 0.80

Routine chest radiographs following repositioning of endotracheal tubes are necessary to assess correct position in pediatric patients. Chest (1994) 0.80

Unintentional perineal injury in prepubescent girls: a multicenter, prospective report of 56 girls. Pediatrics (1995) 0.80

Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation. J Clin Pharmacol (2002) 0.80

Pharmacokinetics of high dose thiotepa in children undergoing autologous bone marrow transplantation. Bone Marrow Transplant (1992) 0.80

Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther (2001) 0.80

Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug Metab Dispos (2001) 0.80

Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep. Crit Care Med (1992) 0.80